Philomaxcap AG: Philomaxcap AG resolves capital increase against cash contributions by way of an accelerated bookbuilding

Munich (pta036/04.06.2025/22:25 UTC+2)

Philomaxcap AG resolves capital increase against cash contributions by way of an accelerated bookbuilding

Munich, June 4, 2025: The Management Board of Philomaxcap AG ("Company", ISIN: DE000A1A6WB2) resolved today with the approval of the Supervisory Board, to increase the company's share capital against cash contributions by issuing new no-par value bearer shares with a pro rata amount of the share capital of EUR 1.00 each ("New Shares"), making partial use of the authorized capital 2024 and excluding shareholders' subscription rights ("Capital Increase"). The capital increase is intended to increase the company's share capital of currently EUR 110,334,081.00 by up to EUR 1,700,000.00 or up to 1.54% by issuing up to 1,700,000 new no-par value bearer shares in the company.

The New Shares will be offered without a prospectus exclusively to institutional investors as part of a private placement by means of an accelerated bookbuilding process and are expected to carry dividend rights from January 1, 2024.

The expected inflow of funds will strengthen the company's equity and will mainly be used to finance the working capital of the wholly owned subsidiary GenH2 Corp. and to accelerate the planned growth of the company.

The private placement will be initiated immediately after this announcement. The number of shares placed as well as the placement price and thus the final gross issue proceeds will be determined and subsequently announced by the Executive Board with the approval of the Supervisory Board after completion of the accelerated bookbuilding process.

End of the adhoc announcement

About Philomaxcap AG (www.philomaxcap.de)

Philomaxcap AG, based in Munich, is a managing holding company focused on the hydrogen industry that provides services for existing and yet-to-be-acquired investments. In 2025, the capital increase by contribution resulted in the full acquisition of GenH2 Corp., a US company specializing in liquid hydrogen technology and equipment.

Service

Investor relations / press contact

Maximilian Fischer, Tel.: +49 89 139 2889 0, e-Mail: m.fischer@philomaxcap.de

Important information:

This announcement is made solely for the purpose of complying with applicable disclosure requirements and does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities of Philomaxcap AG. No public offer has been or will be made and no prospectus has been or will be published in connection with the transactions referred to in this announcement.
The New Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or with any securities regulatory authority of any state of the United States of America.

(end)

Emitter:	Philomaxcap AG Marienplatz 2 80331 München Germany
Contact Person:	Josh McMorrow
Phone:	+49 89 2155 2804
E-Mail:	info@philomaxcap.de
Website:	www.philomaxcap.de
ISIN(s):	DE000A1A6WB2 (Share) DE000A254V53 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Dusseldorf, Stuttgart